UCI’s $12M CIRM award for hNSC-01 marks a pivotal shift to clinical-stage development. See how this state-funded "bridge" is ...
Clinical Trials Arena on MSN
QurAlis announces Phase I QRL-101 trial topline results in ALS
Kv7.2/7.3 channels are voltage-gated potassium channels involved in regulating membrane potential and neuronal excitability.
Cytisinicline likely the best therapy to quit smoking, could be first FDA-approved cessation drug in 20 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback